Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Scope of the Report:
This report focuses on the Hemoperfusion production in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Hemoperfusion production has relatively high technology barrier and is technology intensive industry. The main market players are Baxter (Gambro), Asahi, Kaneka, Toray Medical, etc. The production of hemoperfusion will increase to 1451 K Units in 2016 from 936 K Units in 2011 with average growth rate of 9.17%.
Hemoperfusion mainly has two types, which include charcoal hemoperfusion and certain resins hemoperfusion. With medical effect of hemoperfusion, the downstream application industries will need more hemoperfusion products.
The major raw materials for hemoperfusion are polypropylene, polycarbonate, membrane materials, activated carbon, etc. Fluctuations in the price of the upstream product will impact on the production cost of hemoperfusion, and then impact the price of hemoperfusion. The production cost of hemoperfusion is also an important factor which could impact the price of hemoperfusion. The hemoperfusion manufacturers are trying to produce many more types of hemoperfusion for other different diseases.
We tend to believe this industry is a rising industry, and the consumption increasing degree will show a smooth growth curve. And the price presents decreasing trend according to the economy development status and international competition. Also, there will be decreasing trend in gross margin.
The worldwide market for Hemoperfusion production is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Certain Resins Hemoperfusion
Market Segment by Applications, can be divided into
Liver (Hepatic) Failure
Certain Autoimmune Diseases
There are 15 Chapters to deeply display the global Hemoperfusion production market.
Chapter 1, to describe Hemoperfusion production Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hemoperfusion production, with sales, revenue, and price of Hemoperfusion production, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hemoperfusion production, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hemoperfusion production market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hemoperfusion production sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source